Your SlideShare is downloading. ×
0
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
3 Horrendous Healthcare Stocks This Week   2-14-14
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

3 Horrendous Healthcare Stocks This Week 2-14-14

10,684

Published on

This week's worst-performing healthcare stocks

This week's worst-performing healthcare stocks

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
10,684
On Slideshare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
5
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-affymetrix-inc-shares-dropped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • Transcript

    • 1. 3 Horrendous Health-Care Stocks This Week
    • 2. Much of the U.S. was snowed under this week. Several health-care stocks unfortunately had the same experience -- with shivering plunges in share prices. Source: Wikimedia Commons.
    • 3. Prana Biotechnology (Nasdaq: PRAN) The stock of the biotech focusing on neurological disorders dropped nearly 27% for the week.
    • 4. Why Prana was pummeled • Summer Street analyst Bart Classen cast doubt on prospects for PBT2 in treating Alzheimer’s disease. • Classen thinks Prana’s phase 2b results for PBT2 don’t show statistically significant improvement. • PBT2 is also in phase 2a clinical trials targeting treatment of Huntington’s disease.
    • 5. Galena BioPharma (Nasdaq: GALE) Shares of this biotech careened more than 24% this week.
    • 6. Why Galena shares tanked • TheStreet’s Adam Feuerstein published a damaging article on Wednesday. • The article reported that Galena was linked to a stock-promotions firm that allegedly uses questionable tactics at the same time that insiders were selling. • Galena responded to the article – but only after a huge drop in its stock price.
    • 7. The Medicines Company (Nasdaq: MDCO) The drugmaker’s shares fell nearly 14% this week.
    • 8. Why The Medicines Company shares sank • An FDA advisory committee recommended against approval for antiplatelet agent cangrelor. • Concerns were voiced about the design of cangrelor’s clinical study. • The FDA isn’t bound by the recommendation – and makes its decision for approval by April 30.
    • 9. Best shot at bouncing back? • Galena should have a reasonable chance at rebounding. • Insider selling after rising nearly 250% between Nov. 1 and Jan. 16 isn’t surprising. • Galena’s pipeline holds potential for the future.
    • 10. Find out which stock The Motley Fool’s chief investment officer selected as the top pick for 2014 in our free report!

    ×